Lee CS - Search Results

1

'Real-world' effectiveness of omalizumab in adults with severe allergic asthma: a meta-analysis.

Faulkner KM, MacDonald K, Abraham I, Alhossan A, Lee CS. Faulkner KM, et al. Among authors: lee cs. Expert Rev Clin Immunol. 2021 Jan;17(1):73-83. doi: 10.1080/1744666X.2020.1856658. Epub 2020 Dec 14. Expert Rev Clin Immunol. 2021. PMID: 33307892

2

Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).

Van der Niepen P, Woestenburg A, Brié H, Vancayzeele S, MacDonald K, Denhaerynck K, Lee C, Hermans C, Abraham I. Van der Niepen P, et al. Ann Pharmacother. 2009 May;43(5):849-61. doi: 10.1345/aph.1L576. Epub 2009 Apr 7. Ann Pharmacother. 2009. PMID: 19351876 Clinical Trial.

3

"Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study.

Brusselle G, Michils A, Louis R, Dupont L, Van de Maele B, Delobbe A, Pilette C, Lee CS, Gurdain S, Vancayzeele S, Lecomte P, Hermans C, MacDonald K, Song M, Abraham I. Brusselle G, et al. Among authors: lee cs. Respir Med. 2009 Nov;103(11):1633-42. doi: 10.1016/j.rmed.2009.06.014. Epub 2009 Jul 19. Respir Med. 2009. PMID: 19619998 Free article.

4

Hierarchical linear and logistic modeling of outcomes of antihypertensive treatment in elderly patients: findings from the PREVIEW study.

Abraham I, Demosthenes L, MacDonald K, Lee CS, Reel S, Brié H, Hermans C, Vancayzeele S, Van der Niepen P. Abraham I, et al. Among authors: lee cs. Arch Gerontol Geriatr. 2010 Jul-Aug;51(1):45-53. doi: 10.1016/j.archger.2009.07.009. Epub 2009 Aug 27. Arch Gerontol Geriatr. 2010. PMID: 19716190

5

Background and methodology of MONITOR-GCSF, a pharmaco-epidemiological study of the multi-level determinants, predictors, and clinical outcomes of febrile neutropenia prophylaxis with biosimilar granulocyte-colony stimulating factor filgrastim.

Gascón P, Aapro M, Ludwig H, Rosencher N, Turner M, Song M, MacDonald K, Lee C, Muenzberg M, Abraham I. Gascón P, et al. Crit Rev Oncol Hematol. 2011 Mar;77(3):184-97. doi: 10.1016/j.critrevonc.2010.01.014. Epub 2010 Mar 1. Crit Rev Oncol Hematol. 2011. PMID: 20189821

6

Gender-specific, multi-level determinants of outcomes of antihypertensive treatment: a sub-analysis of the Belgian PREVIEW study.

MacDonald K, Lee CS, Chen HC, Ko ML, Fidel GE, Brié H, Hermans C, Vancayzeele S, Reel S, Van der Niepen P, Abraham I. MacDonald K, et al. Among authors: lee cs. J Hum Hypertens. 2011 Jun;25(6):372-82. doi: 10.1038/jhh.2010.71. Epub 2010 Jul 15. J Hum Hypertens. 2011. PMID: 20631740 Clinical Trial.

7

"Later, lazier, and unluckier": a heuristic profile of high vulnerability is an independent predictor of uncontrolled blood pressure (the PREVIEW study).

Abraham I, Lee C, Song M, Vancayzeele S, Brié H, Hermans C, Van der Niepen P, Macdonald K. Abraham I, et al. Int J Gen Med. 2010 Jul 21;3:163-6. doi: 10.2147/ijgm.s11638. Int J Gen Med. 2010. PMID: 20689688 Free PMC article.

8

Antihypertensive effectiveness of aliskiren for the 'real-world' management of hypertension: multilevel modelling of 180-day blood pressure outcomes (the Belgian DRIVER Study).

Verpooten GA, Aerts A, Coen N, Vancayzeele S, Hermans C, Bowles J, MacDonald K, Abraham I, Lee CS. Verpooten GA, et al. Among authors: lee cs. Int J Clin Pract. 2011 Jan;65(1):54-63. doi: 10.1111/j.1742-1241.2010.02562.x. Int J Clin Pract. 2011. PMID: 21155943 Clinical Trial.

9

Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program.

Abraham I, MacDonald K, Hermans C, Aerts A, Lee C, Brié H, Vancayzeele S. Abraham I, et al. Vasc Health Risk Manag. 2011;7:209-35. doi: 10.2147/VHRM.S9434. Epub 2011 Mar 31. Vasc Health Risk Manag. 2011. PMID: 21490947 Free PMC article. Review.

10

A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 study.

Gesualdo L, London G, Turner M, Lee C, Macdonald K, Goldsmith D, Covic A, Zaoui P, Combe C, Mann J, Dellanna F, Muenzberg M, Abraham I. Gesualdo L, et al. Intern Emerg Med. 2013 Aug;8(5):389-99. doi: 10.1007/s11739-011-0622-7. Epub 2011 May 18. Intern Emerg Med. 2013. PMID: 21590439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,382 results

Search Page